Redmile Group, LLC - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,258,422
-63.7%
3,872,696
-2.1%
0.73%
-55.0%
Q2 2023$42,043,648
+21.8%
3,955,188
-4.6%
1.61%
+7.7%
Q1 2023$34,531,149
+482.3%
4,145,396
+545.3%
1.50%
+516.5%
Q4 2022$5,929,629
-44.7%
642,430
-23.1%
0.24%
-41.6%
Q3 2022$10,732,000
-59.2%
835,830
-58.1%
0.42%
-58.6%
Q2 2022$26,331,000
-38.2%
1,993,268
-1.5%
1.00%
-24.4%
Q1 2022$42,613,000
-20.9%
2,024,368
-9.9%
1.33%
+8.6%
Q4 2021$53,898,000
-11.1%
2,246,668
-5.7%
1.22%
+15.9%
Q3 2021$60,597,000
-26.8%
2,381,958
-3.1%
1.06%
-13.7%
Q2 2021$82,755,000
-16.2%
2,458,558
-3.4%
1.22%
-12.0%
Q1 2021$98,811,000
-40.6%
2,544,062
-5.3%
1.39%
-30.9%
Q4 2020$166,358,000
+94.8%
2,686,234
+5.4%
2.01%
+28.4%
Q3 2020$85,383,000
+43.2%
2,549,506
+1.9%
1.57%
+42.4%
Q2 2020$59,630,000
+20.2%
2,502,306
+15.5%
1.10%
-20.8%
Q1 2020$49,600,000
+71.6%
2,165,938
+112.2%
1.39%
+101.3%
Q4 2019$28,908,000
+32.2%
1,020,778
+0.3%
0.69%
-5.6%
Q3 2019$21,866,000
-26.6%
1,017,478
-0.4%
0.73%
-13.2%
Q2 2019$29,806,0001,021,8080.84%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 16,786,713$562,187,00075.80%
RTW INVESTMENTS, LP 3,544,248$118,697,0002.86%
Cormorant Asset Management, LP 1,537,807$51,501,0001.98%
Redmile Group, LLC 2,549,506$85,383,0001.57%
Birchview Capital, LP 40,000$1,340,0000.45%
HighVista Strategies LLC 17,082$572,0000.42%
Perceptive Advisors 671,978$22,505,0000.33%
GILDER GAGNON HOWE & CO LLC 1,490,153$49,905,0000.31%
Artal Group S.A. 270,750$9,067,0000.22%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 323$11,0000.20%
View complete list of STOKE THERAPEUTICS INC shareholders